94P - Challenges in the management of stage III non-small cell lung cancer (NSCLC) within multidisciplinary team (MDT): A lung cancer center experience
Authors
- K. Harbegue (Ariana, Tunisia)
- N. Mejri (Ariana, Tunisia)
- H. El Benna (Ariana, Tunisia)
- S. Labidi (Ariana, Tunisia)
- N. Daoud (Ariana, Tunisia)
- H. Boussen (Ariana, Tunisia)
Speakers
- K. Harbegue (Ariana, Tunisia)
192P - Characterization and potential role of PD-L1 positive lung cancer stem cells in lymph nodes metastasis
Authors
- A. Raniszewska (Warsaw, Poland)
- E. Rutkowska (Warsaw, Poland)
- R. Sokolowski (Warsaw, Poland)
- J. Domagala-Kulawik (Warsaw, Poland)
Speakers
- A. Raniszewska (Warsaw, Poland)
150P - Characterization of patients with metastatic non-small cell lung cancer obtaining long term benefit from immunotherapy
Authors
- G. Galli (Milan, Italy)
- C. Proto (Milano, Italy)
- D. Signorelli (Milan, Italy)
- M. Imbimbo (Milan, Italy)
- R. Ferrara (Milano, Italy)
- A. Prelaj (Milano, Italy)
- A. De Toma (Milano, Italy)
- G. Randon (Milano, Italy)
- B. Trevisan (Milano, Italy)
- M. Ganzinelli (Milano, Italy)
- N. Zilembo (Milano, Italy)
- M. Garassino (Milan, Italy)
- G. Lo Russo (Milano, Italy)
Speakers
- G. Galli (Milan, Italy)
153P - Chemotherapy with immune-checkpoint inhibitors in first-line treatment metastatic NSCLC patients: Systematic review and literature-based meta-analysis
Authors
- A. Addeo (Geneva, Switzerland)
- G. Banna (Catania, Italy)
- G. Metro (Perugia, (PG), Italy)
- M. Di Maio (Torino, Italy)
Speakers
- A. Addeo (Geneva, Switzerland)
144P - Clinical and treatment features associated with improved 5-year survival rate in ALK-positive lung cancer treated with ALK-TKIs
Authors
- A. Passaro (Milan, Italy)
- A. Prelaj (Milan, Italy)
- G. Spitaleri (Milan, Italy)
- E. Del Signore (Milan, Italy)
- G. Rossi (Milan, Italy)
- E. Guerini-Rocco (Milan, Italy)
- M. Barberis (Milan, Italy)
- C. Catania (Milan, Italy)
- F. De Marinis (Milan, Italy)
Speakers
- A. Passaro (Milan, Italy)
165P - Clinical benefit of anti PD-1/PD-L1 plus chemotherapy versus chemotherapy alone in first-line treatment in advanced non-small cell lung cancer: A meta-analysis
Authors
- T. Landre (Sevran, France)
- G. Des Guetz (Bobigny, CEDEX, France)
- A. Vergnenegre (Limoges, CEDEX, France)
- C. Chouaid (Créteil, CEDEX 12, France)
Speakers
- T. Landre (Sevran, France)
9P - Clinical validation of an NGS-based assay for detecting multiple genomic alterations in Chinese patients with non-small cell lung cancer
Authors
- H. Ge (Xiamen, China)
- X. Chen (Fuzhou, China)
- L. Ruan (Xiamen, China)
- Q. Gao (Xiamen, China)
- X. Yang (Xiamen, China)
- W. Shi (Xiamen, China)
- X. Li (Xiamen, China)
- G. Zhu (Xiamen, China)
Speakers
- H. Ge (Xiamen, China)
12P - Clinicopathologic characteristics of patients with TP63 mutations in Chinese non-small cell lung cancer
Authors
- Q. Zhang (Fuzhou, China)
- C. Xu (Fuzhou, China)
- W. Wang (Zhenjiang, China)
- W. Zhuang (Fuzhou, China)
- Z. Huang (Fuzhou, China)
- G. Chen (Fuzhou, China)
- M. Fang (Zhenjiang, China)
- T. Lv (Nanjing, China)
- Y. Song (Nanjing, China)
Speakers
- Q. Zhang (Fuzhou, China)
35P - Clinicopathological characteristics with genetic profiling and prognostic analysis of primary lymphoepithelioma-like carcinoma in Chinese south-eastern population
Authors
- Y. Shen (Shanghai, China)
- F. Hu (Shanghai, China)
- B. Zhang (Shanghai, China)
- B. Han (Shanghai, China)
Speakers
- Y. Shen (Shanghai, China)
59P - Comparison of internal target volume delineation using CT datasets of four-dimensional computed tomography in lung cancer radiotherapy
Authors
- S. BUSHRA (Mumbai, India)
- A. Tibdewal (Mumbai, India)
- N. Mummudi (Mumbai, India)
- R. Kinhikar (Mumbai, India)
- Y. Ghadi (Mumbai, India)
- J. Agarwal (Mumbai, India)
Speakers
- S. BUSHRA (Mumbai, India)
52P - Concordance, decision impact, and satisfaction for a computerized clinical decision support system in treatment of lung cancer patients
Authors
- K. Lee (Jupiter, United States of America)
- W. Felix (Boston, MA, United States of America)
- G. Jackson (Nashville, TN, United States of America)
Speakers
- K. Lee (Jupiter, United States of America)
152P - Correlation among different KRAS alterations, genetic co-mutations and PD-L1 expression in patients treated with immunotherapy in metastatic NSCLC
Authors
- L. Gianoncelli (Milan, Italy)
- G. Spitaleri (Milan, Italy)
- A. Passaro (Milan, Italy)
- C. Fumagalli (Milan, Italy)
- P. Trillo Aliaga (Milan, Italy)
- E. Del Signore (Roma, Italy)
- V. Stati (Milan, Italy)
- E. Ferraro (Rozzano, (MI), Italy)
- E. Guerini-Rocco (Milan, Italy)
- C. Catania (Milan, Italy)
- M. Barberis (Milan, Italy)
- F. De Marinis (Milan, Italy)
Speakers
- L. Gianoncelli (Milan, Italy)